JO1136B1 - Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration - Google Patents

Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration

Info

Publication number
JO1136B1
JO1136B1 JO19811136A JOP19811136A JO1136B1 JO 1136 B1 JO1136 B1 JO 1136B1 JO 19811136 A JO19811136 A JO 19811136A JO P19811136 A JOP19811136 A JO P19811136A JO 1136 B1 JO1136 B1 JO 1136B1
Authority
JO
Jordan
Prior art keywords
oxidse
inhibitors
oral administration
pharmaceutical formulation
formulation containing
Prior art date
Application number
JO19811136A
Other languages
Arabic (ar)
Inventor
ج كسلر هنرى
هاردن دافيد
جان تورود الان
Original Assignee
ذى ولكم فونديشن ليمتد
ج كسلر هنرى
هاردن دافيد
جان تورود الان
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ذى ولكم فونديشن ليمتد, ج كسلر هنرى, هاردن دافيد, جان تورود الان filed Critical ذى ولكم فونديشن ليمتد
Priority to JO19811136A priority Critical patent/JO1136B1/en
Application granted granted Critical
Publication of JO1136B1 publication Critical patent/JO1136B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PHARMACEUTICAL FORMULATION CONTAINING XANTHINE OXIDSE INHIBITORS FOR ORAL ADMINISTRATION
JO19811136A 1981-01-29 1981-01-29 Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration JO1136B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JO19811136A JO1136B1 (en) 1981-01-29 1981-01-29 Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JO19811136A JO1136B1 (en) 1981-01-29 1981-01-29 Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration

Publications (1)

Publication Number Publication Date
JO1136B1 true JO1136B1 (en) 1983-11-30

Family

ID=48087166

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19811136A JO1136B1 (en) 1981-01-29 1981-01-29 Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration

Country Status (1)

Country Link
JO (1) JO1136B1 (en)

Similar Documents

Publication Publication Date Title
GB2106993B (en) Apparatus for enteral administration of nutriment
GB2142237B (en) Pharmaceutical compositions for percutaneous administration
PT77503A (en) Process for preparing pharmaceutical compositions for oral and/or enteral administration
AU588202B2 (en) Dosage form for delivering acid sensitive beneficial agent
DK163959C (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING CIMETIDIN
EP0202051A3 (en) Therapeutic compositions for oral administration
IL63036A (en) Dosage units for oral administration
MY8600029A (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing themn
ZA828797B (en) Pharmaceutical formulation
NZ218334A (en) Pharmaceutical compositions containing imidazoline derivatives
SG93290G (en) Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
AU551337B2 (en) Pharmaceutical compositions containing oxicam derivatives
GB2085729B (en) Pharmaceutical composition for oral administration containing coagulation factor viii
NZ194901A (en) Device for oral delivery of drug to reticulorumen of ruminant
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
IL90639A (en) Neplanocin derivatives and analogs and pharmaceutical compositions containing them
ZA824789B (en) Indole thomboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
PH22871A (en) Piperazine derivatives and pharmaceutical compositions containing them
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
JO1136B1 (en) Pharmaceutical formulation containing xanthine oxidse inhibitors for oral administration
IL86437A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
DE3163536D1 (en) Pharmaceutical compositions containing two beta-lactam derivatives
GB2142238B (en) Pharmaceutical compositions for percutaneous administration